Clinical Trial Update: Safety, PK and PD Study of ABX464 in Untreated HIV Patients [Phase 2]

View source ↗

Summary

ABX464 was studied for safety, pharmacokinetics and pharmacodynamics in untreated HIV patients in a Phase 2 trial that has completed. The document provides a co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• ABX464 (ABX464)

Snippet

Sponsor: Abivax S.A. | Conditions: Human Immunodeficiency Virus Infections | Phase 2 | Status: COMPLETED